Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 6
1954 3
1955 3
1956 2
1957 3
1958 6
1959 7
1960 2
1961 1
1962 1
1963 1
1964 1
1965 1
1966 1
1969 1
1970 5
1971 1
1972 2
1973 1
1974 1
1975 3
1977 8
1978 5
1979 9
1980 9
1981 10
1982 7
1983 5
1984 11
1985 8
1986 9
1987 5
1988 9
1989 9
1990 13
1991 16
1992 15
1993 5
1994 12
1995 12
1996 12
1997 8
1998 20
1999 9
2000 14
2001 8
2002 10
2003 11
2004 17
2005 12
2006 5
2007 10
2008 11
2009 8
2010 13
2011 21
2012 17
2013 20
2014 17
2015 17
2016 22
2017 20
2018 25
2019 23
2020 33
2021 23
2022 29
Text availability
Article attribute
Article type
Publication date

Search Results

614 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
Brunner HI, Abud-Mendoza C, Viola DO, Calvo Penades I, Levy D, Anton J, Calderon JE, Chasnyk VG, Ferrandiz MA, Keltsev V, Paz Gastanaga ME, Shishov M, Boteanu AL, Henrickson M, Bass D, Clark K, Hammer A, Ji BN, Nino A, Roth DA, Struemper H, Wang ML, Martini A, Lovell D, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). Brunner HI, et al. Among authors: bass d. Ann Rheum Dis. 2020 Oct;79(10):1340-1348. doi: 10.1136/annrheumdis-2020-217101. Epub 2020 Jul 22. Ann Rheum Dis. 2020. PMID: 32699034 Free PMC article. Clinical Trial.
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis.
Rovin BH, Furie R, Teng YKO, Contreras G, Malvar A, Yu X, Ji B, Green Y, Gonzalez-Rivera T, Bass D, Gilbride J, Tang CH, Roth DA. Rovin BH, et al. Among authors: bass d. Kidney Int. 2022 Feb;101(2):403-413. doi: 10.1016/j.kint.2021.08.027. Epub 2021 Sep 22. Kidney Int. 2022. PMID: 34560137 Free article. Clinical Trial.
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.
Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. Stohl W, et al. Among authors: bass d. Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7. Arthritis Rheumatol. 2017. PMID: 28118533 Free PMC article. Clinical Trial.
Kleintiermedizin: Was ist Ihre Diagnose?
Bass D, Schuppisser C, Meier VS. Bass D, et al. Schweiz Arch Tierheilkd. 2021 Apr;163(4):301-308. doi: 10.17236/sat00300. Schweiz Arch Tierheilkd. 2021. PMID: 33821803 Free article. German. No abstract available.
Ascetosporea.
Bass D, Ward GM, Burki F. Bass D, et al. Curr Biol. 2019 Jan 7;29(1):R7-R8. doi: 10.1016/j.cub.2018.11.025. Curr Biol. 2019. PMID: 30620917 Free article. No abstract available.
Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison.
Brunner HI, Abud-Mendoza C, Mori M, Pilkington CA, Syed R, Takei S, Viola DO, Furie RA, Navarra S, Zhang F, Bass DL, Eriksson G, Hammer AE, Ji BN, Okily M, Roth DA, Quasny H, Ruperto N. Brunner HI, et al. Among authors: bass dl. RMD Open. 2021 Sep;7(3):e001747. doi: 10.1136/rmdopen-2021-001747. RMD Open. 2021. PMID: 34531304 Free PMC article.
Parasites, pathogens, and other symbionts of copepods.
Bass D, Rueckert S, Stern R, Cleary AC, Taylor JD, Ward GM, Huys R. Bass D, et al. Trends Parasitol. 2021 Oct;37(10):875-889. doi: 10.1016/j.pt.2021.05.006. Epub 2021 Jun 20. Trends Parasitol. 2021. PMID: 34158247 Review.
614 results